Citicoline for traumatic brain injuries: A systematic review and implications for future research

Document Type : Original Article

Authors

Sina Trauma and Surgery Research Center, Tehran University of Medical Sciences, Tehran, Iran

10.4103/atr.atr_51_22

Abstract

Background and Objectives: Traumatic brain injury (TBI) is a catastrophic condition that exerts a high burden on individuals, families, and societies. The objective of this study was to systematically review the human studies on the efficacy and safety of citicoline for the management of TBIs. Materials and Methods: Relevant articles were identified by searching PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials on July 1, 2022. Results: Eighteen studies met the predefined eligibility criteria, including 12 randomized controlled trials (RCTs). Citicoline was administered via injectional (n = 11, 61.1%), enteral (n = 5, 27.8%), both injectional and enteral (n = 1, 5.5%), and unknown (n = 1, 5.5%) routes. Numerically, studies reporting the favorable impact of citicoline on patient outcome outnumbered (n = 13, 72.2%). However, the largest RCT could not demonstrate positive results. Only two studies reported complications, and the observed difference between citicoline and placebo groups was not statistically significant in either of them. Conclusion: Despite promising results in animal studies, human studies have shown inconsistent results regarding the role of citicoline in TBI management. Homogeneity of patients, subgroups of patients who might benefit more, the efficacy of citicoline as a part of combination therapies, and factors that could potentially influence the pharmacokinetics and brain uptake of citicoline should be considered when designing future studies.

Keywords

References

1.
Consensus conference. Rehabilitation of persons with traumatic brain injury. NIH consensus development panel on rehabilitation of persons with traumatic brain injury. JAMA 1999;282:974-83.  Back to cited text no. 1
    
2.
GBD 2016 Traumatic Brain Injury and Spinal Cord Injury Collaborators. Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990-2016: A systematic analysis for the global burden of disease study 2016. Lancet Neurol 2019;18:56-87.  Back to cited text no. 2
    
3.
Prins M, Greco T, Alexander D, Giza CC. The pathophysiology of traumatic brain injury at a glance. Dis Model Mech 2013;6:1307-15.  Back to cited text no. 3
    
4.
Werner C, Engelhard K. Pathophysiology of traumatic brain injury. Br J Anaesth 2007;99:4-9.  Back to cited text no. 4
    
5.
Kennedy EP, Weiss SB. The function of cytidine coenzymes in the biosynthesis of phospholipides. J Biol Chem 1956;222:193-214.  Back to cited text no. 5
    
6.
Adibhatla RM, Hatcher JF, Dempsey RJ. Citicoline: Neuroprotective mechanisms in cerebral ischemia. J Neurochem 2002;80:12-23.  Back to cited text no. 6
    
7.
D'Orlando KJ, Sandage BW Jr. Citicoline (CDP-choline): Mechanisms of action and effects in ischemic brain injury. Neurol Res 1995;17:281-4.  Back to cited text no. 7
    
8.
Martynov MY, Gusev EI. Current knowledge on the neuroprotective and neuroregenerative properties of citicoline in acute ischemic stroke. J Exp Pharmacol 2015;7:17-28.  Back to cited text no. 8
    
9.
Tower DB, Mceachern D. Acetylcholine and neuronal activity; Cholinesterase patterns and acetylcholine in the cerebrospinal fluids of patients with craniocerebral trauma. Can J Res 1949;27:105-19.  Back to cited text no. 9
    
10.
Dixon CE, Ma X, Marion DW. Reduced evoked release of acetylcholine in the rodent neocortex following traumatic brain injury. Brain Res 1997;749:127-30.  Back to cited text no. 10
    
11.
Ulus IH, Wurtman RJ, Mauron C, Blusztajn JK. Choline increases acetylcholine release and protects against the stimulation-induced decrease in phosphatide levels within membranes of rat corpus striatum. Brain Res 1989;484:217-27.  Back to cited text no. 11
    
12.
Wurtman RJ. Choline metabolism as a basis for the selective vulnerability of cholinergic neurons. Trends Neurosci 1992;15:117-22.  Back to cited text no. 12
    
13.
Blusztajn JK, Liscovitch M, Mauron C, Richardson UI, Wurtman RJ. Phosphatidylcholine as a precursor of choline for acetylcholine synthesis. J Neural Transm Suppl 1987;24:247-59.  Back to cited text no. 13
    
14.
Yen CL, Mar MH, Zeisel SH. Choline deficiency-induced apoptosis in PC12 cells is associated with diminished membrane phosphatidylcholine and sphingomyelin, accumulation of ceramide and diacylglycerol, and activation of a caspase. FASEB J 1999;13:135-42.  Back to cited text no. 14
    
15.
Adibhatla RM, Hatcher JF, Dempsey RJ. Effects of citicoline on phospholipid and glutathione levels in transient cerebral ischemia. Stroke 2001;32:2376-81.  Back to cited text no. 15
    
16.
Mir C, Clotet J, Aledo R, Durany N, Argemí J, Lozano R, et al. CDP-choline prevents glutamate-mediated cell death in cerebellar granule neurons. J Mol Neurosci 2003;20:53-60.  Back to cited text no. 16
    
17.
Qian K, Gu Y, Zhao Y, Li Z, Sun M. Citicoline protects brain against closed head injury in rats through suppressing oxidative stress and calpain over-activation. Neurochem Res 2014;39:1206-18.  Back to cited text no. 17
    
18.
Plataras C, Tsakiris S, Angelogianni P. Effect of CDP-choline on brain acetylcholinesterase and Na(+), K(+)-ATPase in adult rats. Clin Biochem 2000;33:351-7.  Back to cited text no. 18
    
19.
Başkaya MK, Doğan A, Rao AM, Dempsey RJ. Neuroprotective effects of citicoline on brain edema and blood-brain barrier breakdown after traumatic brain injury. J Neurosurg 2000;92:448-52.  Back to cited text no. 19
    
20.
Hurtado O, Moro MA, Cárdenas A, Sánchez V, Fernández-Tomé P, Leza JC, et al. Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: Effects on glutamate transport. Neurobiol Dis 2005;18:336-45.  Back to cited text no. 20
    
21.
Rao AM, Hatcher JF, Dempsey RJ. CDP-choline: Neuroprotection in transient forebrain ischemia of gerbils. J Neurosci Res 1999;58:697-705.  Back to cited text no. 21
    
22.
Chan PH, Fishman RA. The role of arachidonic acid in vasogenic brain edema. Fed Proc 1984;43:210-3.  Back to cited text no. 22
    
23.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 2021;372:n71.  Back to cited text no. 23
    
24.
Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions. BMJ 2016;355:i4919.  Back to cited text no. 24
    
25.
Higgins JP, Altman DG. Assessing risk of bias in included studies. In: Higgins JP, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions. Chichester (UK): John Wiley & Sons; 2008.  Back to cited text no. 25
    
26.
Murad MH, Sultan S, Haffar S, Bazerbachi F. Methodological quality and synthesis of case series and case reports. BMJ Evid Based Med 2018;23:60-3.  Back to cited text no. 26
    
27.
Ahmadi J, Hoseinzadeh-Chahkandak F, Yousefi-Roobiyat M, Pourbagher-Shahri AM, Irankhah S, Rajabpour-Sanati A. Comparison of two different doses of citicoline in patients with traumatic brain injury. J Surg Trauma 2020;8:8-15.  Back to cited text no. 27
    
28.
Aniruddha T, Pillai S, Devi BI, Sampath S, Chandramouli B. Role of citicoline in the management of mild head injury. Indian J Neurotrauma 2009;6:49-52.  Back to cited text no. 28
    
29.
Calatayud Maldonado V, Calatayud Pérez JB, Aso Escario J. Effects of CDP-choline on the recovery of patients with head injury. J Neurol Sci 1991;103 Suppl: S15-8.  Back to cited text no. 29
    
30.
León-Carrión J, Dominguez-Roldán JM, Murillo-Cabezas F, del Rosario Dominguez-Morales M, Muñoz-Sanchez MA. The role of citicholine in neuropsychological training after traumatic brain injury. NeuroRehabilitation 2000;14:33-40.  Back to cited text no. 30
    
31.
Levin HS. Treatment of postconcussional symptoms with CDP-choline. J Neurol Sci 1991;103:S39-42.  Back to cited text no. 31
    
32.
Salehpour F, Aghazade J, Mirzaee F, Mahdkhah A. Citicoline in patients with traumatic brain injuries. EC Neurol 2015;2:87-93.  Back to cited text no. 32
    
33.
Salehpour F, Shokouhi G, Shakeri M, Shimia M, Mahdkhah A, Baradaran A, et al. Neuroprotective effects of citicoline in diffuse axonal injuries. Adv Biosci Clin Med 2013;1:16-9.  Back to cited text no. 33
    
34.
Shokouhi G, Haghjoo AG, Sattarnezhad N, Asghari M, Sattarnezhad A, Asghari A, et al. Effects of citicoline on level of consciousness, serum level of fetuin-A and matrix Gla-protein (MGP) in trauma patients with diffuse axonal injury (DAI) and GCS≤8. Ulus Travma Acil Cerrahi Derg 2014;20:410-6.  Back to cited text no. 34
    
35.
Zafonte R, Friedewald WT, Lee SM, Levin B, Diaz-Arrastia R, Ansel B, et al. The Citicoline Brain Injury Treatment (COBRIT) trial: Design and methods. J Neurotrauma 2009;26:2207-16.  Back to cited text no. 35
    
36.
Zafonte RD, Bagiella E, Ansel BM, Novack TA, Friedewald WT, Hesdorffer DC, et al. Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT). JAMA 2012;308:1993-2000.  Back to cited text no. 36
    
37.
El Reweny EM, Okasha A, Hafez A. The neuro-protective effect of citicholine (CDP CHOLINE) in patients with traumatic brain injury. Intensive Care Med 2012;38:S276.  Back to cited text no. 37
    
38.
Xue GZ, Ou LI, Chun W, Jun ZJ. Therapeutic effects of the citicoline acupuncture point injection in the treatment of memory and cognitive impairment following traumatic brain injury. Brain Inj 2012;26:474-5.  Back to cited text no. 38
    
39.
Cohadon F, Richer E, Poletto B. A precursor of phospholipids in the treatment of severe traumatic comas. Neurochirurgie 1982;28:287-90.  Back to cited text no. 39
    
40.
Mayzner-Zawadzka E, Wodowska M, Toczyłowska B, Ciszek B. Clinical evaluation of the neuroprotective action of CDP choline in isolated brain trauma. Anestezjol Intens Ter 2005;37:246-50.  Back to cited text no. 40
    
41.
Trimmel H, Majdan M, Wodak A, Herzer G, Csomor D, Brazinova A. Citicoline in severe traumatic brain injury: Indications for improved outcome: A retrospective matched pair analysis from 14 Austrian trauma centers. Wien Klin Wochenschr 2018;130:37-44.  Back to cited text no. 41
    
42.
Bermejo Velasco P, Juarez A, Dorado R. Citicoline for mild cognitive impairment in brain damage. Eur J Neurol 2019;26:746.  Back to cited text no. 42
    
43.
Raggueneau JL, Jarrige B. National inquiry on the outcome of severe head injuries: Analysis of 921 injured patients treated with CDP-choline. Agressologie 1988;29:439-43.3.  Back to cited text no. 43
    
44.
Spiers PA, Hochanadel G. Citicoline for traumatic brain injury: Report of two cases, including my own. J Int Neuropsychol Soc 1999;5:260-4.  Back to cited text no. 44
    
45.
Ogashiwa M, Takeuchi K. Intrathecal pharmacotherapy in coma. Acta Neurochir (Wien) 1976;34:37-44.  Back to cited text no. 45
    
46.
Hinev S, Tzoneva D, Ljubenova K, Tzvetkov V, Dimitrov G, Stefanov I. Neuroprotection as component of complex therapy in patients with severe head trauma and cerebrovascular diseases. Anaesthesiol Intensive Care 2007;34:19-24.  Back to cited text no. 46
    
47.
Raggueneau JL, Jarrige B. Epidemiology: Prognosis and outcome of 921 cases of severe brain injuries. Agressologie 1988;29:433-8.  Back to cited text no. 47
    
48.
Secades J. Citicoline for the treatment of head injury: A systematic review and meta-analysis of controlled clinical trials. J Trauma Treat 2014;4:2167-1222.  Back to cited text no. 48
    
49.
Secades JJ. Citicoline: Pharmacological and clinical review, 2016 update. Rev Neurol 2016;63:S1-73.  Back to cited text no. 49
    
50.
Sex differences in traumatic brain injury: A multi-dimensional exploration in genes, hormones, cells, individuals, and society. Chin Neurosurg J 2019;5:24.   Back to cited text no. 50
    
51.
Vagnerova K, Koerner IP, Hurn PD. Gender and the injured brain. Anesth Analg 2008;107:201-14.  Back to cited text no. 51
    
52.
Mikolić A, van Klaveren D, Groeniger JO, Wiegers EJ, Lingsma HF, Zeldovich M, et al. Differences between men and women in treatment and outcome after traumatic brain injury. J Neurotrauma 2021;38:235-51.  Back to cited text no. 52
    
53.
Brickler T, Morton PD, Hazy A, Theus MH. Age-dependent responses following traumatic brain injury. In: Gorbunov NV, Long JB, editors. Traumatic Brain Injury: Pathobiology, Advanced Diagnostics and Acute Management. Rijeka (Croatia): IntechOpen; 2018. p. 21-38.  Back to cited text no. 53
    
54.
Mosenthal AC, Lavery RF, Addis M, Kaul S, Ross S, Marburger R, et al. Isolated traumatic brain injury: Age is an independent predictor of mortality and early outcome. J Trauma 2002;52:907-11.  Back to cited text no. 54
    
55.
Hukkelhoven CW, Steyerberg EW, Rampen AJ, Farace E, Habbema JD, Marshall LF, et al. Patient age and outcome following severe traumatic brain injury: An analysis of 5600 patients. J Neurosurg 2003;99:666-73.  Back to cited text no. 55
    
56.
Hernández AV, Steyerberg EW, Taylor GS, Marmarou A, Habbema JD, Maas AI. Subgroup analysis and covariate adjustment in randomized clinical trials of traumatic brain injury: A systematic review. Neurosurgery 2005;57:1244-53.  Back to cited text no. 56
    
57.
Sabirov D, Krasnenkova M. Different neurotransmitter therapy in severe traumatic brain injury patients: Pilot study. Eur J Anaesthesiol 2014;31:117.  Back to cited text no. 57
    
58.
McInnes K, Friesen CL, MacKenzie DE, Westwood DA, Boe SG. Mild traumatic brain injury (mTBI) and chronic cognitive impairment: A scoping review. PLoS One 2017;12:e0174847.  Back to cited text no. 58
    
59.
Margulies S, Hicks R, Combination Therapies for Traumatic Brain Injury Workshop Leaders. Combination therapies for traumatic brain injury: Prospective considerations. J Neurotrauma 2009;26:925-39.  Back to cited text no. 59
    
60.
Ruff RL, Riechers RG. Effective treatment of traumatic brain injury: Learning from experience. JAMA 2012;308:2032-3.  Back to cited text no. 60
    
61.
Somayaji MR, Przekwas AJ, Gupta RK. Combination therapy for multi-target manipulation of secondary brain injury mechanisms. Curr Neuropharmacol 2018;16:484-504.  Back to cited text no. 61
    
62.
Hatton J. Pharmacological treatment of traumatic brain injury: A review of agents in development. CNS Drugs 2001;15:553-81.  Back to cited text no. 62
    
63.
Fresta M, Wehrli E, Puglisi G. Enhanced therapeutic effect of cytidine-5'-diphosphate choline when associated with GM1 containing small liposomes as demonstrated in a rat ischemia model. Pharm Res 1995;12:1769-74.  Back to cited text no. 63
    
64.
Adibhatla RM. Citicoline in stroke and TBI clinical trials. Nat Rev Neurol 2013;9:173.  Back to cited text no. 64
    
65.
Tan M, Zhu JC, Yin HH. Enteral nutrition in patients with severe traumatic brain injury: Reasons for intolerance and medical management. Br J Neurosurg 2011;25:2-8.  Back to cited text no. 65
    
66.
Hang CH, Shi JX, Sun BW, Li JS. Apoptosis and functional changes of dipeptide transporter (PepT1) in the rat small intestine after traumatic brain injury. J Surg Res 2007;137:53-60.  Back to cited text no. 66
    
67.
Yu XY, Yin HH, Zhu JC. Increased gut absorptive capacity in rats with severe head injury after feeding with probiotics. Nutrition 2011;27:100-7.  Back to cited text no. 67
Archives of Trauma Research
Volume 11, Issue 3
September 2022
Pages 140-149

Files

History

  • Receive Date: 19 June 2023
  • Accept Date: 19 June 2023

Share

How to cite

Statistics